PCSK9 and familial hyperaldosteronism: The genetic defects underlying FH reside either on the LDLR, APOB, PCSK9, or LDLRAP1 genes and result in reduced clearance of plasma LDL by the LDLR pathway leading to lifelong elevations in circulating LDL-C levels (Fig. 1).